Daix (France), New York City (New York, United States), July 9, 2026 – Inventiva (Euronext Paris and

US stock futures lower with Dow down 500 points. Kura Sushi shares drop after reporting worse-than-e

Daix (France),  New York City (New York, United States), July 2, 2026 – Inventiva (Euronext Paris an

Inventiva (IVA) is technically in oversold territory now, so the heavy selling pressure might have e

Europe's largest independent growth debt fund manager has made an investment through its funds,

Claret Capital Partners participates in €130m financing for Inventiva Inventiva is a clinical biopha

Claret Capital Partners is providing growth funding of €43m as part of Inventiva's €130m debt financ

Daix (France), New York City (New York, United States), June 12, 2026 – Inventiva (Euronext Paris an

The heavy selling pressure might have exhausted for Inventiva (IVA) as it is technically in oversold

US stock futures lower, Nasdaq down 1%. Super Micro shares down 8.6% after announcing $7B offering t

Daix (France), New York City (New York, United States), June 9,2026 – Inventiva (Euronext Paris and

Secured a new debt financing with funds and accounts managed by BlackRock and Claret Capital Partner

Daix (France), New York City (New York, United States), June 2, 2026 –  Inventiva (Euronext Paris an

Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and

 Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmace

Daix (France), New York City (New York, United States), June 2, 2026 - Inventiva (Euronext Paris and

Daix (France), New York City (New York, United States), le 2 juin 2026 - Inventiva (Euronext Paris e

Daix (France), New York City (New York, United States), May 26, 2026 – Inventiva (Euronext Paris and

Daix (France), New York (United States), May 21, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (

Inventiva is now essentially a lanifibranor bet. Their prospects hinge on the upcoming Phase 3 NATiV

Daix (France), New York City (New York, United States), May 13, 2026 - Inventiva (Euronext Paris and

Daix (France), New York City (New York, Etats-Unis), le 13 mai 2026 - Inventiva (Euronext Paris et N

U.S. stock futures rise on Tuesday with Dow futures up 400 points. Phreesia shares fall 26.5% in pre

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its s

Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst conse

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of pu

Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-mar

Wall Street analysts changed outlook on top names. Clear Street initiated coverage on RKLB with Buy

Truist Securities analyst Srikripa Devarakonda initiates coverage on Inventiva (NASDAQ:IVA) with

Barclays analyst Eliana Merle initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rati

Leerink Partners analyst Thomas Smith initiates coverage on Inventiva (NASDAQ:IVA) with a Outperf

Guggenheim analyst Seamus Fernandez maintains Inventiva (NASDAQ:IVA) with a Buy and lowers the pr

Following the exercise in full of the Underwriters' Option, the total number of ADSs issued in t

Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinica

Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinica

Wolfe Research analyst Steve Fleishman initiates coverage on Inventiva (NASDAQ:IVA) with a Outper

Companies Reporting Before The Bell • Inventiva (NASDAQ: IVA) is projected to report quarterly loss